In our lab, we are a multidisciplinary team of biologists and chemists in close collaboration with clinicians, radiochemists, physicists and engineers working on a wide variety of research questions in the field of Molecular Imaging and Theranostics. Our goal is the development and clinical translation of molecular imaging and therapy tools for improved tumor detection, intraoperative delineation, patient stratification, treatment optimization and treatment monitoring.We are embedded in the research environment at TranslaTUM and the Nuclear Medicine Department, which allows us to utilize a diverse methodologic portfolio encompassing but not limited to organic synthesis, radiolabeling, HPLC, mass spectrometry, cell culture, in vitro characterization of new tracers, molecular biology e.g. protein expression analysis, confocal microscopy, animal model development, in vivo imaging of new tracers using PET, SPECT and optical imaging, autoradiography and histology. We are employing a growing number of targets for imaging and therapy (=theranostic) applications, including extracellular targets, such as integrins, PSMA, SSTR2 and intracellular targets, e.g. the DNA repair enzyme PARP1.